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ABSTRACT 
The aim of this study was to evaluate wastewater for carbapenemase-producing 
Enterobacteriaceae (CPE) and 16S rRNA methylase-producing Gram-negative 
bacteria (MPB) and to assess their occurrence following wastewater treatment. 
Wastewater samples were collected between June 2015 and March 2016 in the 
sewage network of the city of Basel (Switzerland) from sites located before and after 
influx of wastewater from the hospital into the sewage network. Samples were also 
obtained from the influent and effluent of the receiving wastewater treatment plant. 
Samples were screened for CPE and MPB using selective media. Escherichia coli 
and Klebsiella pneumoniae were typed by multilocus sequence typing (MLST). 
Carbapenemase and 16S rRNA methylase genes were identified by PCR and 
sequencing. Resistance profiles were determined by the disk diffusion test and Etest. 
The occurrence of CPE and MPB was increased downstream of hospital wastewater 
influx. Of 49 CPE isolates, 9 belonged to OXA-48-producing E. coli clone D:ST38, 7 
were OXA-48-producing Citrobacter freundii, and 6 were KPC-2- or OXA-48-
producing K. pneumoniae belonging to clonal complex 258. NDM (NDM-1, -5 and -9) 
and VIM (VIM-1) producers were detected sporadically. MPB included ArmA- and 
RmtB-producing E. coli and Citrobacter spp. Isolates corresponding to strains from 
wastewater were detected in the effluent of the treatment plant. Conclusively, CPE 
and MPB, predominantly OXA-48-producing Enterobacteriaceae, are readily 
detected in wastewater, survive wastewater treatment and are released into the 
aquatic environment. OXA-48-producers may represent an emerging threat to public 
health and environmental integrity. 
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1. Introduction 
Dissemination of carbapenemase-producing Enterobacteriaceae (CPE) is a major 
concern for healthcare providers worldwide. Carbapenemases are b-lactamases, 
usually plasmid-encoded, that hydrolyse almost all b-lactam antibiotics. Most CPE 
are also resistant to multiple other classes of antimicrobials and therefore treatment 
options for infections are limited. Among the few remaining antimicrobials, 
tigecycline, fosfomycin, colistin and aminoglycoside antibiotics (mainly gentamicin) 
are the currently considered chemotherapeutic options for the treatment of severe 
infections caused by multidrug-resistant (MDR) CPE [1]. However, high-level 
resistance to aminoglycosides owing to the production of plasmid-encoded 16S 
rRNA methylase is emerging in Enterobacteriaceae and may be associated with the 
production of carbapenemases [2]. Clinically relevant carbapenemases include the 
class A KPC, the class B metallo-b-lactamases VIM, IMP and NDM, and the class D 
OXA-48-type enzymes [3]. In the hospital setting in Switzerland, CPE are isolated 
predominantly from patients exposed via previous contact with healthcare services in 
CPE-endemic countries such as India, Cyprus, Greece and Italy, whereby the most 
important carbapenemase-producing species continues to be Klebsiella pneumoniae 
[4,5]. However, the last years have seen the emergence of other carbapenemase-
producing species such as Escherichia coli, Enterobacter spp. and Citrobacter spp. 
The development of resistance to carbapenems among E. coli is of particular 
concern because of its potential to disseminate carbapenemases to the community 
and the environment generally, a situation analogous to the global spread of 
extended-spectrum b-lactamases (ESBLs), especially of E. coli sequence type (ST) 
131 harbouring blaCTX-M-15, during the last decade [4]. One of the most pressing 
challenges is to determine reservoirs and transmission pathways of CPE and other 
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MDR bacteria in order to reduce the risk to public health. Wastewater has repeatedly 
been described to reflect the current status of antibiotic-resistant bacteria in the 
population [6,7]. Hospital wastewater (HWW) is reported to serve as an important 
reservoir of CPE [8], however the correlation between clinical isolates of CPE and 
CPE isolated from HWW remains unclear [9,10]. The aim of this study was to 
evaluate the presence of CPE and 16S rRNA methylase-producing bacteria (MPB) in 
wastewater. Samples were collected over a 9-month period from different sites within 
the sewage disposal network of the city of Basel, Switzerland. The sites under 
scrutiny corresponded to municipal wastewater (MWW), HWW, treatment plant 
influent (TPI) and treatment plant effluent (TPE). Isolates were examined for (i) 
species identity, phylogenetic group or multilocus sequence type (MLST), (ii) 
carbapenemase or 16S rRNA methylase genes, ESBL genes and the plasmid-
mediated colistin resistance gene mcr-1 and (iii) antimicrobial susceptibility profile. 
 
2. Materials and methods 
2.1. Study setting and sampling 
This study targeted multiple sites within the sewage disposal network of the city of 
Basel, including sites sampled upstream and downstream of the wastewater 
discharge of the University Hospital of Basel, a tertiary care centre admitting more 
than 32 000 adult patients per year. Wastewater accrues from the city of Basel, 
which has a current population of 190 000, as well as 11 surrounding communities, 
excluding wastewater from the chemical and pharmaceutical industry, which is 
treated in a separate chemical wastewater treatment plant (WWTP). The WWTP 
processes 100 million litres of raw sewage per day using a primary sedimentation 
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basin, secondary biological treatment tanks and a final secondary sedimentation 
basin. Treated water is released directly into the River Rhine. 
 
Sampling took place on seven occasions between June 2015 and March 2016. 
Sewage water samples were taken from a total of 10 sites, representing four 
different types of wastewater: four sampling sites (denoted as sites I–IV), 
representing MWW, were located ca. 250, 330, 500 and 730 m upstream of four 
sewage discharge sites of the University Hospital Basel. Four sampling sites 
(denoted as V–VIII), representing HWW, were located immediately downstream of 
the four hospital discharge sites. Sampling site IX, representing wastewater TPI, was 
located at the inlet of the WWTP, at a distance of ca. 4000 m from sites V–VIII. 
Sampling site X, representing TPE, was situated at the final outlet channel of the 
WWTP. 
 
For analysis of MWW and HWW, samples from sites I–IV and sites V–VIII, 
respectively, were pooled on each sampling occasion. 
 
2.2. Bacterial isolation 
For each water sample, 50 mL was passed through a 0.45 µm filter (Millipore, 
Billerica, MA). Filters were incubated for 24 h at 37 °C in 10 mL of 
Enterobacteriaceae enrichment broth (Becton Dickinson, Heidelberg, Germany) for 
enrichment. Screening for CPE was performed by streaking one loopful of enriched 
culture onto chromID® CARBA SMART and one loopful onto chromID® OXA-48 
(bioMérieux, Marcy-l’Étoile, France). Screening for aminoglycoside-resistant Gram-
negative bacteria was conducted using Luria Bertani agar (Difco Laboratories, 
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Franklin Lakes NJ, USA) containing amikacin (200 mg/L), vancomycin (10 mg/L) and 
amphotericin B (5 mg/L). All colonies with different morphologies were picked, 
subcultured and purified on chromID® CARBA SMART/chromID® OXA-48 or on 
selective medium with amikacin, respectively. Oxidase-negative, presumptive 
carbapenemase-producers were further subcultured on Müller–Hinton agar (Becton 
Dickinson, Allschwil, Switzerland) plates and were subsequently screened for 
carbapenemase activity using the RAPIDEC® CARBA NP test (bioMérieux). Isolates 
were subjected to identification by protein profiling using matrix-assisted laser 
desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF/MS) (AXIMA 
Confidence; Shimadzu-Biotech Corp., Kyoto, Japan) using SARAMISTM Database 
(Spectral Archive and Microbial Identification System; AnagnosTec, Potsdam-Golm, 
Germany) and PAPMID Database (Mabritec SA, Riehen, Switzerland). Strains 
yielding doubtful results were subjected to genetic identification based on 
sequencing of the rpoB gene fragment [11]. 
 
2.3. Phylogenetic classification of Escherichia coli isolates 
Each E. coli isolate was assigned to one of the four phylogenetic groups designated 
A, B1, B2 or D using PCR as described previously [12], whereby group A and B1 
typically contain commensal E. coli strains, whilst groups B2 and D consist of virulent 
extraintestinal strains. 
 
2.4. Multilocus sequence typing of Escherichia coli and Klebsiella pneumoniae 
For MLST of E. coli isolates, internal fragments of seven housekeeping genes (adk, 
fumC, gyrB, icd, mdh, purA and recA) were amplified by PCR and were sequenced 
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as described by Wirth et al. [13]. Sequences were imported into the E. coli MLST 
database website (http://mlst.ucc.ie/mlst/dbs/Ecoli) to determine sequence types 
(STs). 
 
MLST of the K. pneumoniae isolates was performed by PCR amplification and 
sequencing of seven housekeeping genes (gapA, infB, mdh, pgi, phoE, rpoB and 
tonB) according to previously described methods [14]. STs were determined 
according to the MLST database (http://bigsdb.pasteur.fr/klebsiella/). 
 
Alleles and STs that had not been previously described were submitted to the 
curators of the databases and were assigned new designations. 
 
2.5. Detection of antimicrobial resistance genes 
DNA was extracted by a standard heat lysis protocol and was analysed by PCR for 
the presence of antimicrobial resistance genes. Synthesis of primers and custom 
DNA sequencing were carried out by Microsynth (Balgach, Switzerland). Purification 
of amplicons was performed using a PCR purification kit (Sigma-Aldrich, Buchs, 
Switzerland). All presumptive carbapenemase-producers were screened for the 
presence of blaVIM, blaKPC, blaNDM-1 and blaOXA-48 using previously described primers 
[15,16]. 
 
Isolates exhibiting an ESBL phenotype were screened for blaTEM, blaSHV and blaCTX-M 
genes using previously published primers [17,18]. Presumptive 16S rRNA 
methylase-producers were analysed for the presence of armA, rmtA, rmtB, rmtC and 
rmtD as described previously [19]. All isolates were screened for the presence of the 
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plasmid-mediated colistin resistance gene mcr-1 using primers published recently 
[20]. Nucleotide sequences were analysed with CLC Main Workbench 7.7 (CLC bio, 
Aarhus, Denmark). Database searches were performed using the BLASTN program 
of the National Center for Biotechnology Information (NCBI) 
(http://www.ncbi.nlm.nih.gov/blast/). 
 
2.6. Antimicrobial susceptibility testing 
Minimum inhibitory concentrations (MIC) of imipenem, ertapenem and meropenem 
for CPE and of amikacin, kanamycin and gentamicin for MPB were determined by 
Etest (bioMérieux) according to the manufacturer’s instructions and Clinical and 
Laboratory Standards Institute (CLSI) evaluation criteria [21]. All isolates were tested 
for susceptibility to 13 antimicrobial agents by the disk diffusion method. Zone 
diameters were determined and evaluated according to CLSI protocols and criteria 
[21]. The antibiotics tested were ampicillin, amoxicillin/clavulanic acid, cefalotin, 
cefotaxime, nalidixic acid, ciprofloxacin, gentamicin, kanamycin, streptomycin, 
sulfamethoxazole, trimethoprim, chloramphenicol and tetracycline (Becton 
Dickinson, Heidelberg, Germany). Multidrug resistance was defined as resistance to 
three or more classes of antimicrobials. 
 
3. Results 
3.1. Detection and characterisation of bacteria 
Presumptive carbapenemase-producers were recovered from all wastewater types 
within the sewage disposal network (Table 1; Supplementary Table S1). A total of 2 
CPE isolates were retrieved from MWW, 23 from HWW, 10 from TPI and 14 from 
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TPE. In total 49 CPE isolates were retrieved, including 21 E. coli, 12 K. pneumoniae, 
8 Citrobacter freundii, 1 Citrobacter youngae, 5 other Citrobacter spp., 1 
Enterobacter aerogenes and 1 Enterobacter cloacae. Typing of the E. coli isolates 
placed 10 (47.6%) within phylogenetic group A and clonal complex (CC) 10, and 9 
(42.9%) within phylogenetic group D and CC38. The remaining isolates belonged to 
various STs (Table 1). Typing of the K. pneumoniae isolates identified six (50%) 
belonging to CC258. Other STs, including two new types ST2256 and ST2257, are 
listed in Table 1. No E. coli B2:ST131 clones were identified in any of the wastewater 
samples. 
 
Isolates expressing high resistance to aminoglycosides were recovered from HWW, 
TPI and TPE. These isolates were identified as E. coli (n = 8), belonging to ST10, 
ST635, ST648 and ST1266, and Citrobacter spp. (n = 2) (Table 1). 
 
3.2. Characterisation of antimicrobial resistance genes 
All detected resistance genes are listed in Supplementary Table S1. The majority of 
CPE isolates (35/49; 71.4%) from the chromID® CARBA SMART/chromID® OXA-48 
plates harboured blaOXA-48. Six (12.2%) of the isolates were blaNDM-producers (two 
blaNDM-1, three blaNDM-5 and one blaNDM-9). Five (10.2%, all K. pneumoniae) isolates 
tested positive for blaKPC, three (6.1%) contained blaOXA-181 and four (8.2%) 
harboured blaVIM (Table 1). Four (8.2%) of the isolates produced more than one 
carbapenemase: one E. coli D:ST393 and one C. freundii strain possessed both 
blaOXA-48 and blaVIM-1. Similarly, two Citrobacter spp. carried both blaOXA-48 and 
blaNDM-1. Twenty-five (51.0%) of the CPE isolates also contained blaCTX-M genes. Of 
these, 14 (56.0%) were blaCTX-M-15, 6 (24.0%) were blaCTX-M-3, 3 (12.0%) were blaCTX-
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M-24 and 2 (8.0%) were blaCTX-M-14. Two (4.1%) of the 49 CPE contained blaSHV-12. 
The gene blaCTX-M-3 was observed only in Citrobacter spp., and blaSHV-12 was 
detected in Citrobacter spp. (Supplementary Table S1). The two blaNDM-1 harbouring 
Citrobacter spp. isolates were additionally tested for the presence of 16S rRNA 
methylase genes, and armA was detected (Table 1). 
 
Of the eight methylase-producing E. coli strains isolated from the selective medium 
with amikacin, five (62.5%) harboured rmtB and three (37.5%) contained armA 
(Table 1). Furthermore, one isolate contained blaNDM-5, one possessed blaCTX-M-65 
and two isolates contained blaCTX-M-55 and blaCTX-M-65, respectively (Supplementary 
Table S1).  
None of the CPE or MPB possessed the colistin resistance gene mcr-1. 
 
3.3. Antimicrobial susceptibility profiles 
MICs and the results of the disk diffusion tests for each isolate are listed in 
Supplementary Table S1. Regarding multidrug resistance, 39 (79.6%) of the 49 CPE 
and all 10 (100%) MPB were MDR. Six (28.6%) carbapenemase-producing E. coli 
(four NDM, one VIM-1 and one OXA-181 producer) and seven (58.3%) K. 
pneumoniae (five KPC, one OXA-48 and one NDM-9 producer) exhibited resistance 
to one or more carbapenems. Of the 35 OXA-48-producers, 5 (14.3%) were 
classified as resistant to one or more carbapenems according to current CLSI 
guidelines. 
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3.4. Isolation frequency for sampling occasions 
A large proportion of the study isolates (19 of the CPE and 2 of the MPB) were 
retrieved sporadically (on one sampling occasion each). CPE that were detected on 
two occasions included K. pneumoniae belonging to CC258, RmtB-producing E. coli 
A:ST10 and ArmA-producing E. coli B2:ST1266 (Table 1). OXA-48-producing C. 
freundii were recovered on four sampling occasions and from HWW, TPI and TPE. 
The most frequently encountered clone, OXA-48-producing E. coli D:ST38, was 
isolated on five occasions and was the only clone detected simultaneously in MWW, 
HWW, TPI and TPE. 
 
4. Discussion 
This study was carried out to determine the occurrence of CPE and MPB at different 
sites of the sewage disposal network of the city of Basel, Switzerland, including 
before and after influx of wastewater from the hospital into the sewage network and 
the WWTP. Whilst the presence of CPE and other antimicrobial-resistant bacteria in 
HWW and within treatment plants is reported in the literature [9,22,23], little is known 
so far about the presence of CPE in MWW. In this study, MWW contained NDM-5-
producing E. coli A:ST617. NDM-5 was first described in a clinical E. coli clone 
ST648 isolate in the UK in 2011 [24]. To our knowledge, NDM-5 has not been 
described in ST617 before and its identification not only in MWW but also in TPI and 
TPE discharged into the River Rhine indicates that NDM-5-producers may be 
widespread in the community and in the aquatic environment. Furthermore, OXA-48-
producing E. coli D:ST38 was isolated from MWW. Its detection in MWW as well as 
HWW, TPI and TPE provides further evidence for the spread of this clone in the 
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community and healthy carriers, as described recently [25]. HWW contained a higher 
number of CPE isolates compared with MWW, including KPC- and OXA-48-
producing K. pneumoniae belonging to CC258, a lineage that is the most prevalent 
cause of MDR K. pneumoniae infections in many countries [26,27]. HWW also 
contained a large number of OXA-48-producing Citrobacter spp. The occurrence of 
OXA-48-producing Citrobacter spp. in HWW over a period of several months may be 
due to their regular discharge from the hospital or to the persistence of these isolates 
in the wastewater environment. Of note are two Citrobacter spp. isolates (one from 
HWW and one from TPE) with an interesting genotypic and phenotypic similarity to a 
C. freundii urinary clinical isolate of a patient hospitalised previously in the University 
Hospital of Basel [28]. These isolates co-harboured blaOXA-48, blaNDM-1, blaSHV-12, 
blaCTX-M-15 and armA and were resistant to b-lactams, the carbapenem compound 
ertapenem, aminoglycosides, fluoroquinolones and folic acid pathway inhibitors. For 
further comparison and clarification of the species identification, whole-genome 
sequencing is currently in progress and will be reported on later. This study has 
several limitations. First, not all morphologically identical colonies that were 
recovered from the water samples on selective plates were analysed. Thus, some 
resistant strains may have been missed. Therefore, the actual occurrence of CPE 
and MPB in wastewater may be even higher than observed. Second, it was not 
possible to directly compare the wastewater isolates with clinical isolates from the 
hospital, as no monitoring data or isolates from clinical cases from this hospital were 
available. The current findings highlight the need for further studies dedicated to 
correlating the presence of wastewater-associated CPE with human clinical isolates. 
Testing municipal and hospital wastewater for CPE or other antimicrobial-resistant 
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bacteria may also represent an approach to recognise emerging trends in resistance 
and the burden of faecal carriage in the population. 
 
In TPI and TPE, carbapenemase-producing and methylase-producing isolates of 
clonal types that were identical to those found in MWW or HWW (mainly OXA-48-
producing E. coli ST38 and OXA-48-producing Citrobacter spp.) were detected. This 
finding indicates that these isolates possess the ability to persist within wastewater 
and to survive the wastewater treatment process. Furthermore, some of the clones 
detected in TPE in this study have been described previously in clinical case reports 
or hospital outbreaks, such as OXA-181-producing E. coli ST410 [29] and OXA-48-
producing K. pneumoniae ST29 and ST395 [30,31]. Other clones identified in this 
study such as E. coli ST393 and ST354 have been reported previously as ESBL-
producers [32] but not, to our knowledge, as carbapenemase-producers. As 
mentioned in Section 3.1, a considerable fraction of CPE and MPB from the 
wastewater analysed in this study were commensal E. coli belonging to CC10. 
Strains belonging to this clonal complex have been observed to contribute 
significantly to the spread of ESBLs [33,34]. Hence, the detection of 
carbapenemases and 16S rRNA methylases in CC10 isolates in wastewater is of 
concern and supports the hypothesis of horizontal gene transmission by plasmid-
mediated mechanisms among Enterobacteriaceae [32]. In contrast, no E. coli 
B2:ST131 isolates were detected. There is growing concern that this international 
extraintestinal pathogenic clone may be currently involved in the global 
dissemination of KPC-2 and other carbapenemases [35]. Data from the current study 
indicate that to date, the wastewater and TPE analysed in this study do not represent 
a reservoir for KPC-2-producing E. coli ST131. Although several studies have 
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described KPC- and VIM-producers in HWW [36], the current data indicate that 
OXA-48-producing Enterobacteriaceae, in particular E. coli and Citrobacter spp., 
may represent the greater threat to public health and environmental integrity. 
 
In conclusion, wastewater is a reservoir of viable CPE and methylase-producing 
clones harbouring clinically relevant carbapenemases. Moreover, the purification 
process employed in the WWTP does not sufficiently reduce the burden of such 
MDR isolates, which are subsequently released into the aquatic environment. 
Additional wastewater treatment processes are urgently required in order to reduce 
MDR bacteria of anthropogenic origin in wastewater, in particular primary treatment 
of hospital effluents prior to discharge into the sewage network. 
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